Jo Piper
Impact in
- Infectious Diseases top 0.5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Modeling and Simulation top 1%
- COVID-19 epidemiological studies
Papers in
-
- SARS-CoV-2 and COVID-19 Research 4
- COVID-19 Clinical Research Studies 1
-
- Regulation of Appetite and Obesity 1
- Journals
- The Lancet (2 papers)Resuscitation (1 paper)The Lancet Infectious Diseases (1 paper)Med (1 paper)ESMO Open (1 paper)
- Partner nations
- United KingdomEstonia
In The Last Decade
Jo Piper
7 papers receiving 4.7k citations
Jo Piper's Hit Papers
Peers
Comparison fields: 5 of 118
- Infectious Diseases 3.4k
- Modeling and Simulation 292
- Health 355
- Toxicology 86
- Neurology 144
Countries citing papers authored by Jo Piper
This map shows the geographic impact of Jo Piper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jo Piper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jo Piper more than expected).
Fields of papers citing papers by Jo Piper
This network shows the impact of papers produced by Jo Piper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jo Piper. The network helps show where Jo Piper may publish in the future.
Co-authors
The 2 scholars most cited alongside Jo Piper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK Hit paper breakdown → | 2020 | 3698 |
| 2 | Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials Hit paper breakdown → | 2021 | 894 |
| 3 | 2022 | 138 | |
| 4 | 2005 | 122 | |
| 5 | 2024 | 4 | |
| 6 | 2018 | 3 | |
| 7 | 2021 | 2 |
About Jo Piper
Jo Piper is a scholar working on Infectious Diseases, Endocrine and Autonomic Systems, Cancer Research, Genetics and Epidemiology, having authored 7 papers that have together received 4.9k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (4 papers), Ethics in Clinical Research (1 paper), COVID-19 Clinical Research Studies (1 paper), Cancer Genomics and Diagnostics (1 paper), Adipokines, Inflammation, and Metabolic Diseases (1 paper), Regulation of Appetite and Obesity (1 paper), Healthcare Technology and Patient Monitoring (1 paper) and Genetic Associations and Epidemiology (1 paper). The work is most often cited by research in Infectious Diseases (3.4k citations), Modeling and Simulation (292 citations), Health (355 citations), Toxicology (86 citations) and Neurology (144 citations). Jo Piper has collaborated with scholars based in United Kingdom and Estonia. Frequent co-authors include Debbie Knight and Gary B. Smith. Their work appears in journals such as The Lancet, Resuscitation, The Lancet Infectious Diseases, Med and ESMO Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.